Anti-Apolipoprotein(a) Antibody Biotinylated
| Catalog number: | B2012781 |
| Lot number: | Batch Dependent |
| Expiration Date: | Batch dependent |
| Amount: | 100 ug |
| Molecular Weight or Concentration: | 501.3 kDa |
| Supplied as: | Solution |
| Applications: | molecular tool for various biochemical applications |
| Storage: | 2-8C |
| Keywords: | Anti-Apolipoprotein(a) Antibody, clone LPA4 Antibody, Biotin Conjugate |
| Grade: | Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um. |
References
- Radwan MM, El-Lebedy D, Fouda R, Elsorougy E. Anti-apolipoprotein A-1 antibodies and carotid intima-media thickness in Egyptian women with systemic lupus erythematosus Clin Rheumatol. 2014 Apr;33(4):493-8.
- LHuillier AG, Pagano S, Baggio S, Meyer B, Andrey DO, Nehme M, Guessous I, Eberhardt CS, Huttner A, Posfay-Barbe KM, Yerly S, Siegrist CA, Kaiser L, Vuilleumier N. Autoantibodies against apolipoprotein A-1 after COVID-19 predict symptoms persistence Eur J Clin Invest. 2022 Oct;52(10):e13818.
- Adam S, Ho JH, Liu Y, Siahmansur T, Iqbal Z, Pagano S, Azmi S, Dhage SS, Donn R, Ammori BJ, Syed AA, Durrington PN, Malik RA, Vuilleumier N, Soran H. Bariatric Surgery Leads to a Reduction in Antibodies to Apolipoprotein A-1: a Prospective Cohort Study Obes Surg. 2022 Feb;32(2):355-364.
- Rudewicz-Kowalczyk D, Grabowska I. Antibody-Ferrocene Conjugates as a Platform for Electro-Chemical Detection of Low-Density Lipoprotein Molecules. 2022 Aug 26;27(17):5492.
- Pagano S, Yerly S, Meyer B, Juillard C, Suh N, Le Terrier C, Daguer JP, Farrera-Soler L, Barluenga S, Piumatti G, Hartley O, Lemaitre B, Eberhardt CS, Siegrist CA, Eckerle I, Stringhini S, Guessous I, Kaiser L, Pugin J, Winssinger N, Vuilleumier N. SARS-CoV-2 infection as a trigger of humoral response against apolipoprotein A-1 Eur J Clin Invest. 2021 Nov;51(11):e13661.
- Vuilleumier N, Rossier MF, Pagano S, Python M, Charbonney E, Nkoulou R, James R, Reber G, Mach F, Roux-Lombard P. Anti-apolipoprotein A-1 IgG as an independent cardiovascular prognostic marker affecting basal heart rate in myocardial infarction Eur Heart J. 2010 Apr;31(7):815-23.
- Montecucco F, Vuilleumier N, Pagano S, Lenglet S, Bertolotto M, Braunersreuther V, Pelli G, Kovari E, Pane B, Spinella G, Pende A, Palombo D, Dallegri F, Mach F, Roux-Lombard P. Anti-Apolipoprotein A-1 auto-antibodies are active mediators of atherosclerotic plaque vulnerability Eur Heart J. 2011 Feb;32(4):412-21.
- Teixeira PC, Cutler P, Vuilleumier N. Autoantibodies to apolipoprotein A-1 in cardiovascular diseases: current perspectives Clin Dev Immunol. 2012;2012:868251.
- da Silva RF, Baptista D, Roth A, Miteva K, Burger F, Vuilleumier N, Carbone F, Montecucco F, Mach F, Brandt KJ. Anti-Apolipoprotein A-1 IgG Influences Neutrophil Extracellular Trap Content at Distinct Regions of Human Carotid Plaques Int J Mol Sci. 2020 Oct 19;21(20):7721.
